Protagonist Therapeutics (PTGX) Q4 2025 Earnings

6NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.63
0.24
1.11
1.98

Details

Expected EPS
-0.626933
Actual EPS
-0.62
Surprise EPS
0.01
Surprise Percent
+1.11%

Description

Protagonist Therapeutics (PTGX) has reported earnings of -0.62 per share for Q4 2025.

0 Comments

Share your thoughts